Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1Dermatologic 1

Conditions

Ovarian Neoplasms 1Melanoma 1Margins of Excision 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

fludarabine phosphate 7Mycophenolic Acid 6Peripheral Blood Stem Cell Transplantation 5Cyclosporine 5Whole-Body Irradiation 4Cyclophosphamide 3Antilymphocyte Serum 3temsirolimus 2Tacrolimus 2Sunitinib 2Radiotherapy 2Methotrexate 2Counseling 2Busulfan 2Bupropion 2varlilumab 1ulixertinib 1trastuzumab biosimilar HLX02 1trametinib 1thymoglobulin 1tanespimycin 1sapanisertib 1romidepsin 1relatlimab 1pertuzumab 1peginterferon alfa-2a 1palbociclib 1osimertinib 1omipalisib 1larotrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Renal Cell × varlilumab × Other hematologic neoplasm × Clear all
NCT01460134 2018-01-31

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Celldex Therapeutics

Phase 1 Completed
90 enrolled
DermatologicGenitourinaryGynecologicLymphoidOther hematologic neoplasmThoracic

Margins of Excision, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Ovarian Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡